Abstract
Cellular barriers, such as the skin, the lung epithelium or the intestinal epithelium, constitute one of the first obstacles facing
nanomedicines or other nanoparticles entering organisms. It is thus important to assess the capacity of nanoparticles to enter and
transport across such barriers. In this work, Caco-2 intestinal epithelial cells were used as a well-established model for the intestinal
barrier, and the uptake, trafficking and translocation of model silica nanoparticles of different sizes were investigated using a com-
bination of imaging, flow cytometry and transport studies. Compared to typical observations in standard cell lines commonly used
for in vitro studies, silica nanoparticle uptake into well-developed Caco-2 cellular barriers was found to be very low. Instead, nano-
particle association to the apical outer membrane was substantial and these particles could easily be misinterpreted as internalised in
the absence of imaging. Passage of nanoparticles through the barrier was very limited, suggesting that the low amount of inter-
nalised nanoparticles was due to reduced uptake into cells, rather than a considerable transport through them.
nanomedicines or other nanoparticles entering organisms. It is thus important to assess the capacity of nanoparticles to enter and
transport across such barriers. In this work, Caco-2 intestinal epithelial cells were used as a well-established model for the intestinal
barrier, and the uptake, trafficking and translocation of model silica nanoparticles of different sizes were investigated using a com-
bination of imaging, flow cytometry and transport studies. Compared to typical observations in standard cell lines commonly used
for in vitro studies, silica nanoparticle uptake into well-developed Caco-2 cellular barriers was found to be very low. Instead, nano-
particle association to the apical outer membrane was substantial and these particles could easily be misinterpreted as internalised in
the absence of imaging. Passage of nanoparticles through the barrier was very limited, suggesting that the low amount of inter-
nalised nanoparticles was due to reduced uptake into cells, rather than a considerable transport through them.
Original language | English |
---|---|
Pages (from-to) | 1396-1406 |
Number of pages | 11 |
Journal | Beilstein Journal of Nanotechnology |
Volume | 8 |
DOIs | |
Publication status | Published - 7-Jul-2017 |
Keywords
- SIZE
- NANOTECHNOLOGY
- BLOOD-BRAIN-BARRIER
- PROTEIN CORONA
- POLYSTYRENE NANOPARTICLES
- POLYMERIC NANOPARTICLES
- DRUG PERMEABILITY
- IN-VITRO
- CELLS
- TRANSPORT